Ledger.Open graph →

SEC Form D · filed March 24, 2015

Vaxin Inc

Offering

$42.0M

Sold

$42.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

GAITHERSBURG, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Philip Hodges · Gaithersburg, MDDirector Philippe Pouletty · Gaithersburg, MDDirector William Enright · Gaithersburg, MDExec · Director David Drutz · Gaithersburg, MDDirector Klaus Schafer · Gaithersburg, MDDirector Scot Roberts · Gaithersburg, MDExec Marten Steen · Gaithersburg, MDDirector Florent Gros · Gaithersburg, MDDirector Laren C. Gillespie · Grand Cayman, Cayman IslandsDirector Russell R. Stanton · Lunenburg, MADirector Adeline R. Harris · Grass Valley, CAExec Eugene R. Gregerson · Bolton, MADirector Hansen R. Yuan · Naples, FLExec · Director Michael R. Sinsheimer · Charlotte, NCExec · Director Hunter Connelly · Nashville, TNDirector Aaron White · Nashville, TNDirector Vivek Farias · Boston, MAExec · Director Vivek Mehra · Boston, MADirector Devavrat Shah · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗